These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes. Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals. Bruegger C; Kempf W; Spoerri I; Arnold AW; Itin PH; Burger B Exp Dermatol; 2013 Jun; 22(6):426-8. PubMed ID: 23711067 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055 [TBL] [Abstract][Full Text] [Related]
7. miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS. Neu J; Dziunycz PJ; Dzung A; Lefort K; Falke M; Denzler R; Freiberger SN; Iotzova-Weiss G; Kuzmanov A; Levesque MP; Dotto GP; Hofbauer GFL PLoS One; 2017; 12(9):e0185028. PubMed ID: 28931048 [TBL] [Abstract][Full Text] [Related]
8. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells. Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809 [TBL] [Abstract][Full Text] [Related]
10. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma. Kim BK; Kim I; Yoon SK J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma. Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008 [TBL] [Abstract][Full Text] [Related]
12. MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas. Stojadinovic O; Ramirez H; Pastar I; Gordon KA; Stone R; Choudhary S; Badiavas E; Nouri K; Tomic-Canic M Arch Dermatol Res; 2017 Mar; 309(2):133-139. PubMed ID: 28013372 [TBL] [Abstract][Full Text] [Related]
13. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4. Wang J; Li C; Xu L; Yang C; Zhang X Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326 [TBL] [Abstract][Full Text] [Related]
14. MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1. Lohcharoenkal W; Li C; Das Mahapatra K; Lapins J; Homey B; Sonkoly E; Pivarcsi A J Invest Dermatol; 2021 Aug; 141(8):1922-1931. PubMed ID: 33766507 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Li XF; Yan PJ; Shao ZM Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247 [TBL] [Abstract][Full Text] [Related]